Stereochemistry | ACHIRAL |
Molecular Formula | C10H7N4O5.K |
Molecular Weight | 302.2847 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[K+].[O-][N+](=O)C1=CC=C(O1)\C=C\C=N\N2CC(=O)[N-]C2=O
InChI
InChIKey=ZKIAXFGFUSGPGQ-NGTWICJZSA-M
InChI=1S/C10H8N4O5.K/c15-8-6-13(10(16)12-8)11-5-1-2-7-3-4-9(19-7)14(17)18;/h1-5H,6H2,(H,12,15,16);/q;+1/p-1/b2-1+,11-5+;
Molecular Formula | K |
Molecular Weight | 39.0983 |
Charge | 1 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C10H8N4O5 |
Molecular Weight | 264.1943 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Optical Activity | NONE |
Furagin (Furazidine) is a nitrofuran derivative, acting as an antibacterial medicine with bacteriostatic action. It is active against both gram-positive (Staphylococcus epidermidis, Staphylococcus aureus, Staphylococcus faecalis) and gram-negative microorganisms (Enterobacteriaceae – Salmonella, Shygella, Proteus, Klebsiella, Escherichia, Enterobacter, etc.). It is used for the treatment of urinary tract, skin and soft tissues infections.
Approval Year
PubMed
Sample Use Guides
Adults: 50-100 mg t.i.d., for 7-14 days.
0.5% or 1% solution for topical applications.
Route of Administration:
Other